Jewell Marcus 4
Research Summary
AI-generated summary
Cellebrite (CLBT) Global CRO Jewell Marcus Sells 12,658 Shares
What Happened
- Jewell Marcus, Global Chief Revenue Officer of Cellebrite DI Ltd. (CLBT), sold 12,658 shares on 2026-05-18. The weighted-average sale price reported is $12.77, yielding gross proceeds of approximately $161,657. The filing notes the shares were RSUs granted on November 15, 2023, and the disposition was associated with tax obligations tied to the RSU vesting.
Key Details
- Transaction date: 2026-05-18
- Transaction type/code: Sale (S) — open market or private sale
- Shares sold: 12,658
- Weighted-average price: $12.77; price range across multiple trades: $12.43 to $12.9807
- Gross proceeds: ~$161,657
- Shares owned after transaction: Not specified in the provided filing
- Notable footnotes: Shares were RSUs granted 11/15/2023; sale related to tax obligations on vesting (footnote F1). Reporting person can provide a per-price breakdown on request (footnote F2).
- Filing timeliness: Report filed 2026-05-19 (one day after the transaction) — appears timely.
Context
- This sale stems from vested restricted stock units and associated tax withholding obligations, a common reason insiders sell shares that does not necessarily signal a change in view on the company. For retail investors, purchases by insiders often carry more informational weight than routine sales to cover taxes.